Per Patient Reimbursment (CTBM100C2412): A multi-center, human factors engineering (HFE) usability study in cystic fibrosis patients to validate the approved instructions for use(IFU) of TOBI® Podhaler? (tobramycin inhalation powder) using placebo capsu